NCT00822783View on ClinicalTrials.gov

Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

October 31, 2001

Study Completion Date

April 30, 2003

Conditions

Atopic Dermatitis

Interventions

DRUG

Omalizumab

DRUG

Placebo

Trial Locations (1)

1090 Vienna

Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Medical University of Vienna, Austria., Vienna, Waehringer Guertel 18-20

All Listed Sponsors

lead

Medical University of Vienna

OTHER

NCT00822783 - Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients | Biotech Hunter | Biotech Hunter